US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing

      The recalled hoses can burst, posing an impact hazard and a risk of temporarily impaired hearing. … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Marlex Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Due to Label Mix-Up

Marlex Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Due to Label Mix-Up

August 30, 2023 By The FDA Leave a Comment

Summary

Company Announcement Date:
August 30, 2023
FDA Publish Date:
August 31, 2023
Product Type:
Drugs

Reason for Announcement:

Recall Reason Description

Label Mix-Up

Company Name:
Marlex Pharmaceuticals, Inc.
Brand Name:

Brand Name(s)

Marlex Pharmaceuticals, Inc.

Product Description:

Product Description

Digoxin Tablets USP, 0.125mg and 0.25mg


Company Announcement

FOR IMMEDIATE RELEASE – August 30, 2023 – New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125mg and one lot of Digoxin Tablets USP, 0.25mg to the consumer level due to Label Mix-Up. Bottles of Digoxin Tablets, USP 0.125mg s are incorrectly labeled and contain Digoxin Tablets USP, 0.25mg Tablets. Bottles of Digoxin Tablets USP, 0.25mg are incorrectly labeled and contain Digoxin Tablets USP, 0.125mg.

Digoxin Tablets USP, 0.125mg are yellow, circular, beveled, uncoated tablets scored between “N” and “201” on one side and plain on the other side.

Digoxin Tablets USP, 0.25mg are white to off-white, circular. beveled, uncoated tablets scored between “N” and “202” on one side and plain on the other side.

Risk Statement: The mix-up in labels can cause either overdosing or underdosing in patients who unknowingly take the wrong dose. Patients who intend to take Digoxin Tablets USP, 0.125mg, but unknowingly Digoxin 0.25mg would receive a super potent dose and can experience significant drug toxicity (mental disorientation, dizziness, blurred vision, memory loss and fainting) from the unintentional overdose. Patients who intend to take Digoxin Tablets USP, 0.25mg, but unknowingly take Digoxin 0.125mg would receive a sub potent dose which may lead to loss of control of heart rate and potential heart failure exacerbation. Marlex Pharmaceuticals, Inc has not received any reports of adverse events related to this recall.

The product is used for the treatment of mild to moderate heart failure. Digoxin increases heart muscle contraction in pediatric patients with heart failure. Digoxin is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation. The product is packaged as 100 tablets in white HDPE bottles and labeled as indicated below with NDC, lot and expiration date.

Digoxin 0.125mg Tablet – NDC 10135-0747-01, lot# E3810, expiration 2/2025

Digoxin 0.25mg Tablet – NDC 10135-0748-01, lot# E3811, expiration 2/2025

Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Product were distributed Nationwide.

Consumers/distributors/retailers that have Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg (lot# E3810 and lot# E3811) which are being recalled should stop using/return to place of purchase. Marlex Pharmaceuticals, Inc. is notifying its distributors and customers by emails and is arranging for return of all recalled products (lot# E3810 and lot# E3811).

Consumers with questions regarding this recall can contact Marlex Pharmaceuticals, Inc. by phone number 302-328-3355 or toll free 888-582-1953 on Monday – Friday from 8.30AM and 4:30PM, EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


Company Contact Information

Consumers:
Marlex Pharmaceuticals, Inc
302-328-3355 or toll free 888-582-1953


Product Photos

  • Label for Digoxin Tablets USP, 0.125mg

  • Label for Digoxin Tablets USP, 0.25mg

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing

July 23, 2025 By The CPSC

Curtis International Recalls Frigidaire-brand Minifridges Due to Fire and Burn Hazards; More Than $700,000 Reported in Property Damage

July 23, 2025 By The CPSC

Pura Scents Recalls Detachable Covers of Smart Home Fragrance Diffusers Due to Magnet Ingestion Hazard

July 23, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

LED Gloves Recalled Due to Risk of Serious Injury or Death from Battery Ingestion; Violates the Mandatory Toy Standard and Child Resistant Coin Battery Packaging Standard; Sold on Amazon by Minongad

July 23, 2025 By The CPSC

Diamond G Forest Products Recalls Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

Innovative Designs Recalls Minecraft Light-Up Slap Ruler Bracelets Due to Risk of Serious Injury or Death from Button Cell Battery Ingestion Hazard; Violates Mandatory Standard for Toys

July 23, 2025 By The CPSC

Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

FENGQS Electric Bikes Recalled Due to Fire and Burn Hazards; Risk of Serious Injury or Death; Sold on Amazon

July 23, 2025 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

FENGQS Electric Bikes Recalled Due to Fire and Burn Hazards; Risk of Serious Injury or Death; Sold on Amazon

July 23, 2025 By The CPSC

Aiho Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment; Violates Mandatory Standard; Sold on Walmart.com by Aiho

July 23, 2025 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing
  • Curtis International Recalls Frigidaire-brand Minifridges Due to Fire and Burn Hazards; More Than $700,000 Reported in Property Damage
  • Pura Scents Recalls Detachable Covers of Smart Home Fragrance Diffusers Due to Magnet Ingestion Hazard
  • iMirror Inc. Recalls Electric Bug Zapper Racket, Fly Swatter, and Mosquito Swatter Due to Shock Hazard
  • Transpro US Recalls Electric Scooters with Unauthorized Lithium-Ion Battery UL Certification Labels Due to Fire and Burn Hazards; Risk of Serious Injury and Death; $200,000 in Property Damage Reported
  • LED Gloves Recalled Due to Risk of Serious Injury or Death from Battery Ingestion; Violates the Mandatory Toy Standard and Child Resistant Coin Battery Packaging Standard; Sold on Amazon by Minongad
  • Diamond G Forest Products Recalls Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging
  • Innovative Designs Recalls Minecraft Light-Up Slap Ruler Bracelets Due to Risk of Serious Injury or Death from Button Cell Battery Ingestion Hazard; Violates Mandatory Standard for Toys
  • Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in